Healthcare -
Biotechnology - NASDAQ - US
$ 0.96
-5.88 %
$ 200 M
Market Cap
-1.35
P/E
SGMO - NET INCOME
Net Income SGMO - Sangamo Therapeutics, Inc.
-258 M
LAST VALUE
-20.25%
2 YEAR CAGR
-30.21%
5 YEAR CAGR
-25.49%
10 YEAR CAGR